HNRNPK

Heterogeneous nuclear ribonucleoprotein K · P61978 · HNRNPK on Sugi Atlas →

0 patent compounds predicted against HNRNPK, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to HNRNPK by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Evaluating Efficacy of Tivozanib (AV-951) in Biliary Tract Cancers PHASE1/PHASE2RECRUITING
Testing Nivolumab and BMS-986016 (Relatlimab) as Potentially Targeting Treatment in Cancers That Are LAG-3+ and Have Mismatch Repair Deficiency (MATCH - Subprotocol Z1M) PHASE2WITHDRAWN
Testing Crizotinib as a Potential Targeted Treatment in Cancers With ALK Genetic Changes (MATCH-Subprotocol F) PHASE2ACTIVE_NOT_RECRUITING
Testing Dasatinib as a Potential Targeted Treatment in Cancers With DDR2 Genetic Changes (MATCH-Subprotocol X) PHASE2WITHDRAWN
Testing Trametinib as a Potential Targeted Treatment in Cancers With NF1 Genetic Changes (MATCH-Subprotocol S1) PHASE2ACTIVE_NOT_RECRUITING
Expression Pattern of HNRNPH1 and HNRNPK Genes in MPNs nanUNKNOWN
Longitudinal Study of Neurogenetic Disorders nanRECRUITING
Diagnosis of Inflammatory Bowel Disease nanNOT_YET_RECRUITING
Association of SNPs in Long Intergenic Noncoding RNA 00511 (LINC00511) With Breast Cancer Among the Egyptian Population nanCOMPLETED
MiRNA223 and HMGB1 as Apredictos for Drug Resistant Epilepsy nanUNKNOWN
LINC00511/miR-185-3p Axis and miR-301a-3p Markers for Breast Cancer Diagnosis nanCOMPLETED
Aberrant Splicings Due to Microsatellite Instability in Colorectal Cancer : Physiopathological and Clinical Impact nanUNKNOWN
Role of SF3B1 Mutation in Assessment of Acute and Chronic Lymphatic Leukemia nanNOT_YET_RECRUITING
Dried Fruit and Postprandial Glycemia Trial nanUNKNOWN
Immunophenotyping and Xist Gene in AML nanUNKNOWN
Na+ Channel mRNA Regulation in Heart Failure nanCOMPLETED
Mechanisms of Cell Death in Spinal Muscular Atrophy nanCOMPLETED
Risk of HCC in Cirrhotic Patients Post DAAs Ttt nanUNKNOWN
Micro Ribosomal Nucleic Acid 155 in Non Hodgkin Lymphoma nanCOMPLETED
MicroRNA-1 (miRNA-1) and MicroRNA-133a (miRNA-133a) Levels After Acute Exercise in Ultimate Frisbee Athletes nanUNKNOWN
Biocollection in MyeloDysplastic Syndrome (P-MDS) nanRECRUITING
Research on Effects of Acute Consumption of Nuts in Obese Diabetic Women nanRECRUITING
SMN Circular RNAs as Potential Biomarkers for the Therapeutic Response to Nusinersen in Spinal Muscular Atrophy Patients nanUNKNOWN
Smoker Extracellular Vesicles Influence on Human Bronchial Epithelial Cells nanCOMPLETED
Identification of New FTLD Genes nanUNKNOWN
Patient's Derived Organoids for Drug Screening in Glioblastoma nanNOT_YET_RECRUITING
Transcriptomes Breast, Ovarian and Leukocyte Hereditary Genes Predisposing to Breast and / or Ovarian Cancer nanCOMPLETED
Hippotherapy in Children With Spinal Muscular Atrophy nanRECRUITING
EKLF Gene Expression in β-thalassemia nanNOT_YET_RECRUITING
Clinical Manifestations and Biomarkers in Amyotrophic Lateral Sclerosis Type 4 and Other Inherited Neurological Disorders of RNA Processing nanRECRUITING

Related proteins — ESM-2 sequence neighbours (a HNRNPK binder may also engage these)

ProteinNameSimilarity
Q3T0D0 1.000 Q3T0D0 →
Q5R5H8 1.000 Q5R5H8 →
P61979 1.000 P61979 →
O19049 1.000 O19049 →
P61980 1.000 P61980 →
Q4R4M6 0.999 Q4R4M6 →
Q5ZIQ3 0.998 Q5ZIQ3 →
P91277 0.988 P91277 →
Q8VH51 0.975 Q8VH51 →
P90978 0.973 P90978 →
Q7TMK9 0.972 Q7TMK9 →
SYNCRIP Heterogeneous nuclear ribonucleoprotein Q 0.972 landscape →
P90727 0.972 P90727 →
Q7TP47 0.972 Q7TP47 →
O74919 0.972 O74919 →
Q9NFU0 0.971 Q9NFU0 →
P25555 0.971 P25555 →
RBM39 RNA-binding protein 39 0.971 landscape →
Q5SF07 0.971 Q5SF07 →
Q94901 0.970 Q94901 →
P87253 0.970 P87253 →
IGF2BP2 Insulin-like growth factor 2 mRNA-binding protein 2 0.970 landscape →
A7VJC2 0.969 A7VJC2 →
Q5RBU8 0.969 Q5RBU8 →
Q4WXV6 0.969 Q4WXV6 →
Q9C7C3 0.969 Q9C7C3 →
A6ZKR5 0.969 A6ZKR5 →
Q5RC80 0.969 Q5RC80 →
A6R3L3 0.969 A6R3L3 →
P13230 0.968 P13230 →